Health
Study shows reliability and robustness of injectable anti-obesity medication – News-Medical.Net
A second study of the injectable anti-obesity medication, semaglutide, has confirmed the large weight losses reported in a study earlier this month, establishing…
A second study of the injectable anti-obesity medication, semaglutide, has confirmed the large weight losses reported in a study earlier this month, establishing the reliability and robustness of this new drug. With obesity affecting more than 40 percent of American adults, the findings could have a major impact on weight management in primary care and other settings. The study is published today in the Journal of the American Medical Association.
The 68-week study was conducted at 41 sites in the…
-
Noosa News16 hours agoJessica Alba spotted filming spy thriller on the Gold Coast as cameras roll under iconic bridge
-
Noosa News12 hours agoDavid’s neighbour died alone. He now knows what comes next
-
Noosa News12 hours agoNoosa Council targeted in fraud
-
Noosa News21 hours agoGood Charlotte are Touring Australia and New Zealand in 2026